Novavax
NVAX
#5569
Rank
ยฃ0.94 B
Marketcap
ยฃ5.81
Share price
-3.99%
Change (1 day)
14.71%
Change (1 year)

Novavax (NVAX) - Total assets

Total assets on the balance sheet as of December 2025 : ยฃ0.88 Billion

According to Novavax's latest financial reports the company's total assets are ยฃ0.88 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novavax - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31ยฃ0.87 B-29.74%
2024-12-31ยฃ1.24 B-11.87%
2023-12-31ยฃ1.41 B-24.43%
2022-12-31ยฃ1.86 B-2.2%
2021-12-31ยฃ1.90 B64.43%
2020-12-31ยฃ1.16 B780.21%
2019-12-31ยฃ0.13 B-19.5%
2018-12-31ยฃ0.16 B-26.8%
2017-12-31ยฃ0.22 B-29.96%
2016-12-31ยฃ0.31 B22.67%
2015-12-31ยฃ0.26 B46.95%
2014-12-31ยฃ0.17 B24.37%
2013-12-31ยฃ0.14 B125.11%
2012-12-31ยฃ63.32 M47.83%
2011-12-31ยฃ42.83 M-11.65%
2010-12-31ยฃ48.48 M-8.35%
2009-12-31ยฃ52.9 M1.18%
2008-12-31ยฃ52.28 M13.77%
2007-12-31ยฃ45.95 M-26.15%
2006-12-31ยฃ62.22 M27.16%
2005-12-31ยฃ48.93 M20.45%
2004-12-31ยฃ40.62 M-13.65%
2003-12-31ยฃ47.04 M31.18%
2002-12-31ยฃ35.86 M-22.52%
2001-12-31ยฃ46.28 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
ยฃ83.72 B 9,330.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ157.08 B 17,593.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ86.08 B 9,595.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ62.11 B 6,896.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
ยฃ2.52 B 184.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ0.43 B-50.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ0.17 B-80.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
ยฃ6.3 M-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ0.38 B-56.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ1.10 B 24.18%๐Ÿ‡บ๐Ÿ‡ธ USA